Neomycin and related aminoglycosidic antibiotics displace calcium from synaptosomes of guinea pig cerebral cortex and from preparations of phosphatidylinositol diphosphate. At low drug concentrations, inhibition of synaptosomal calcium binding is competitive (Ki = 3" 10 -s M), at high concentrations it is non-competitive (K i = 4.10 -4 M). Monomolecular films of phosphatidylinositol diphosphate are contracted by low concentrations of neomycin in the subphase, and are expanded at high concentrations. This expansion persists even at the collapse pressure indicating a strong interaction between the drug and the lipid.
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Summary
Neomycin and related aminoglycosidic antibiotics displace calcium from synaptosomes of guinea pig cerebral cortex and from preparations of phosphatidylinositol diphosphate. At low drug concentrations, inhibition of synaptosomal calcium binding is competitive (Ki = 3" 10 -s M), at high concentrations it is non-competitive (K i = 4.10 -4 M). Monomolecular films of phosphatidylinositol diphosphate are contracted by low concentrations of neomycin in the subphase, and are expanded at high concentrations. This expansion persists even at the collapse pressure indicating a strong interaction between the drug and the lipid.
Neomycin, streptomycin and related aminoglycosidic antibiotics exert two types of toxic actions on mammalian tissues. Neuromuscular and ganglionic toxicity are acute effects antagonized by Ca 2 +, while chronic application of these drugs leads to irreversible cochlear and to renal damage [1] . Concentration-dependent dual effects of aminoglycosides on some tissues have been reported. In the small intestine of the rat, 6 mM neomycin reversibly increases glucose absorption while 18 mM drug irreversibly inhibits it [2] . Streptomycin suppresses the microphonic output of the fish lateral line organ reversibly at concentrations around 2" 10 -s M and irreversibly at concentration tions above 10 -2 M [3] .
We have recently demonstrated an inhibition by neomycin of polyphosphoinositide metabolism in vivo in the inner ear [4] of chronically treated guinea pigs. In vitro, this antibiotic was shown to interfere with polyphosphoinositide metabolism and calcium binding in inner ear tissues [4] and with lipid labeling in synaptosomes from cerebral cortex [5] . We, therefore, investigated possible correlations between the neomycin action on calcium binding and on polyphosphoinositides with synaptosomal membranes and with monomolecular films of phosphatidylinositol diphosphate.
Neomycin which inhibits calcium binding at the vascular smooth muscle [6] is also a potent inhibitor of calcium binding to synaptosomal membranes (Table I ). The structurally related antibiotics tobramycin, gentamicin and kanamycin show similar activity. Of the various drug fragments tested, the most effective were neamine and neobiosamine, which are moieties of neomycin. At low concentrations neomycin inhibits calcium binding competitively but at higher concentrations the inhibition is non-competitive (Fig. 1) . This was confirmed in several independent experiments with different synaptosomal preparations. From these experiments constants were calculated [ 7] for calcium binding (Km = 6" 10 -4 M), for the competitive inhibition by neomycin (K i = 3" 10 -s M) and the non-competitive inhibition (K i = 4" 10 -4 M).
Both proteins and lipids are calcium binding sites in biological membranes but drug-calcium interactions generally involve calcium bound to phospholipids [8] . In view of the neomycin action on polyphosphoinositide metabolism and the known capability of phosphatidylinositol diphosphate to form calcium salts in vitro [9] , we investigated neomycin interactions with this lipid. Calcium bound to a phosphatidylinositol diphosphate preparation is readily displaced by neomycin (Table II) . In phosphatidylinositol diphosphate rich monolayers, the addition of 10 -2 M Ca 2+ to the subphase results in a condensation of the film (Fig. 2) . Neomycin, at 10 -3 M, produces a strong condensation at low film pressures. As the surface pressure is increased, the condensation effect diminishes and the curve becomes almost superimposable with the standard curve at about 30 dynes/cm. The presence of 10 -2 M neomycin in the subphase causes a significant expansion of the film which is evident even at the collapse pressure. This indicates a strong interaction between the lipid and neomycin at this drug concentration.
TABLE I INHIBITION OF CALCIUM BINDING BY AMINOGLYCOSIDIC ANTIBIOTICS AND FRAGMENTS
Lysed synaptosomes (0.5 mg protein) prepared from guinea pig cerebral cortex as described previously [10] , were incubated for 15 rain at 37°C in 100 mM sodium-HEPES, pH 7.4, and 0.1/~Ci (0.1 raM) 4SCaC12, volume 0.5 ml. Bound calcium was assayed by centrifugal sedimentation [4] . Numbers are means of at least duplicate determinations. In all experiments: neomycin = neomycin B.
Calcium bound (% of control) I  I --[  --I  I  I  I  ]~  I  T  I  [  I  T~  I  I  I  I  I-I --T  I The film balance assembly has been described previously [12] . The subphase consisted of 0.1 M Tris chloride, pH 7.4, and NaC1 to give an ionic strength of 0.2. Approximately 40 #g phosphatidylinositol diphosphate (see legend to Table II) in hexanol/ethanol (9 : 1, by vol.) were spread over the subphase with an Agla micrometer syringe. Surface area of the trough was 15 cm x 30 cm (100% area on x-axis). 45 rain were allowed for equilibration prior to compression of the film, and one minute was allowed between each area change. CaC12 or neomycin were added to the subphase in the concentrations indicated. Each point is the mean of duplicate determinations.
-4 M drug -3 M
In summary, we have demonstrated an interaction of neomycin with calcium binding in synaptosomal membranes and with monomolecular films of phosphatidylinositol phosphate. It is intriguing that in both systems the drug exerts a dual effect, as its pharmacological actions also seem to show two distinct mechanisms. It remains to be established, however, how the in vitro effects on calcium binding and on polyphosphoinositides relate to each other and to the in vivo toxicity of neomycin.
